Cargando…

Drug Use Evaluation of Tamoxifen Focusing on Off-Label Use in a Managed Care Population in Israel

BACKGROUND: Policy development to manage new off-label uses of medications is an issue relevant to health policy stakeholders internationally. Retrospective drug utilization analyses may be useful to identify practice trends in the use of drugs for unapproved (off-label) uses. Since drug use evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kahan, Natan R., Waitman, Dan-Andrei, Blackmon, Shimon, Vardy, Daniel A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2010
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438203/ https://www.ncbi.nlm.nih.gov/pubmed/20518588 http://dx.doi.org/10.18553/jmcp.2010.16.5.355

Ejemplares similares

Suboptimal Pneumococcal Pneumonia Vaccination Rates Among Patients at Risk in a Managed Care Organization in Israel
por: Kahan, Natan R., et al.
Publicado: (2006)

Profiling off-label prescriptions in cancer treatment using social health networks
por: Nikfarjam, Azadeh, et al.
Publicado: (2019)

Utilization of Emergency Department Services by the Bedouin Population in Southern Israel
por: Cohen, Arnon Dov, et al.
Publicado: (2007)

Telithromycin: The Perils of Hasty Adoption and Persistence of Off-Label Prescribing
por: Gleason, Patrick P., et al.
Publicado: (2007)

COVID-19 and off label use of drugs: an ethical viewpoint
por: Shojaei, Amirahmad, et al.
Publicado: (2020)

Utilisation of drugs for the treatment of psychiatric diseases in the pediatric population: focus on off-label use
por: Pesiou, Stella, et al.
Publicado: (2023)

Time to Mammographic Density Decrease After Exposure to Tamoxifen
por: Bäcklund, Magnus, et al.
Publicado: (2022)

Off-label use of rituximab in dermatology: pemphigus treatment
por: Bomm, Lislaine, et al.
Publicado: (2013)

Off-Label Use vs Off-Label Marketing of Drugs: Part 1: Off-Label Use—Patient Harms and Prescriber Responsibilities
por: Van Norman, Gail A.
Publicado: (2023)

Change in Estradiol Levels among Premenopausal Patients with Breast Cancer Treated Using Leuprolide Acetate 11.25 Milligrams 3-Month Depot and Tamoxifen
por: Lee, Young-jin, et al.
Publicado: (2020)

Paediatric drug use with focus on off-label prescriptions at Swedish hospitals – a nationwide study
por: Kimland, E, et al.
Publicado: (2012)

Israel 1960 : (algunas impresiones de la vida cotidiana)
por: Kahan, Salomon
Publicado: (1961)

The March of the Beetles: Epistatic Components Dominate Divergence in Dispersal Tendency in Tribolium castaneum
por: Ruckman, Sarah N, et al.
Publicado: (2020)

Ghosts of a Structured Past: Impacts of Ancestral Patterns of Isolation-by-Distance on Divergence-Time Estimation
por: Hancock, Zachary B, et al.
Publicado: (2020)

Automated Detection of Off-Label Drug Use
por: Jung, Kenneth, et al.
Publicado: (2014)

Use of Balanced Solutions is Prudent as the Mainstay of Fluid Management in Off Pump Coronary Surgery
por: Nagre, Amarja S., et al.
Publicado: (2022)

Off-Label and Off-NCCN Guidelines Uses of Antineoplastic Drugs in China
por: WANG, Weilan, et al.
Publicado: (2013)

Paediatric drug use with focus on off-label prescriptions in Swedish outpatient care – a nationwide study
por: Olsson, J, et al.
Publicado: (2011)

The evolutionary dynamics of haplodiploidy: Genome architecture and haploid viability
por: Blackmon, Heath, et al.
Publicado: (2015)

Drug utilization in neonatal setting of Pakistan: focus on unlicensed and off label drug prescribing
por: Aamir, Muhammad, et al.
Publicado: (2018)

Multiple drugs: Various toxicities, off-label use and no response to off-label therapy: case report
Publicado: (2021)

Association of CYP2D6 genotype and tamoxifen metabolites with breast cancer recurrence in a low-dose trial
por: DeCensi, Andrea, et al.
Publicado: (2021)

Off-label use of drugs: An evil or a necessity?
por: Gota, Vikram, et al.
Publicado: (2015)

Off-label drugs use in pediatric palliative care
por: De Zen, Lucia, et al.
Publicado: (2018)

Recommendations on Off-Label Drug Use in Pediatric Guidelines
por: Meng, Min, et al.
Publicado: (2022)

Impact of Label Restriction on Checkpoint-Inhibitor Use in Bladder Cancer and Changes in Mortality
por: Vader, Daniel T, et al.
Publicado: (2022)

Multiple drugs: Drugs ineffective and off-label use: case report
Publicado: (2022)

Importance of highly selective LC–MS/MS analysis for the accurate quantification of tamoxifen and its metabolites: focus on endoxifen and 4-hydroxytamoxifen
por: Jager, N. G. L., et al.
Publicado: (2012)

Pharmacotherapy of Schizophrenic Patients: Preponderance of Off-Label Drug Use
por: Pickar, David, et al.
Publicado: (2008)

Regulating off-label drug use in India: The arena for concern
por: Oberoi, Sukhvinder Singh
Publicado: (2015)

Multiple drugs: Lymphocytopenia and off-label use: case report
Publicado: (2020)

Multiple drugs: Bradycardia and off-label use: case report
Publicado: (2021)

Safety Consequences of Off-Label Drugs Used for COVID-19
por: Dasgupta, Nabarun
Publicado: (2021)

Multiple drugs: No response and off label use: case report
Publicado: (2021)

Multiple drugs: No response and off-label use: case report
Publicado: (2021)

Multiple drugs: Infections and off label use: case report
Publicado: (2021)

Multiple drugs: No improvement and off label use: case report
Publicado: (2022)

Editorial: Investigating drugs used off-label in various cancers
por: Liu, Wang, et al.
Publicado: (2023)

Off-label use information in electronic drug information resources
por: Rothgeb, Amanda, et al.
Publicado: (2022)

Use of Drugs for Off-Label Indications: Living in the Same World
por: Barbuto, John P.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_pp1ca8a57kddt2iai9btt22utl